Trigemina, Inc. (TI), a Mountain View based startup, has begun a Phase IIa clinical trial for its lead molecule in Chronic Daily Headache (CDH) in collaboration with Dr. Egilius Spierings at MedVadis Research Corporation located outside of Boston. The study compares intranasal oxytocin with placebo in patients suffering from at least 15 days of headache pain per month…
Workers and residents exposed to dust and fumes caused by the collapse of the World Trade Center on September 11, 2001 frequently reported headache years later, according to research released that will be presented at the American Academy of Neurology’s 62nd Annual Meeting in Toronto April 10 to April 17, 2010…
People with migraine may be at an increased risk of heart attack and other risk factors for heart disease, according to a study published in the February 10, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology…
Migraine sufferers are twice as likely to have heart attacks as people without migraine, according to a new study by researchers at Albert Einstein College of Medicine of Yeshiva University…
A preliminary study suggests the same type of botulinum injection used for cosmetic purposes may be associated with reduced frequency of migraine headaches that are described as crushing, vicelike or eye-popping (ocular), but not pain that is experienced as a buildup of pressure inside the head, according to a report in the February issue of Archives of Dermatology, one of the …
Migraine is seen more frequently in women with multiple sclerosis (MS) than those without, according to a study released today that will be presented at the American Academy of Neurology’s 62nd Annual Meeting in Toronto April 10 to April 17, 2010…
Research published ahead of print in the Journal of Neurology Neurosurgery and Psychiatry reports that chronic migraine sufferers tend to be in poorer general health, less wealthy, and more depressed than those with episodic migraine. Episodic migraine is a severe headache happening up to 14 days of the month. Chronic migraine is headache happening 15 or more days of the month…
An article published Online First and in the April edition of The Lancet Neurology reports that a new hand-held device that delivers a magnetic pulse to the back of the head could be a promising non-invasive, non-drug treatment option for patients with migraine. This device offers efficient pain relief for up to 48 hours after treatment in some patients with migraine with aura…
One of the most common questions I am asked after someone hits their head is, “How serious is this bump on my head and should I make an appointment?” Head injuries are the result of trauma to the scalp, skull or brain. Concussion, the most common type of traumatic brain injury (TBI), is an injury that occurs after a blow to the head and results in a temporary loss of consciousness…
Researchers in the US believe they have discovered why light can make the pain of migraine worse, even in some blind people: they found photoreceptors in a part of the brain called the thalamus appear to process both light and pain, revealing for the first time that it is possible for neural pathways for pain and non-image-forming light sensitivity to converge…
MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) announced that the U.S. Food and Drug Administration (FDA) has informed the Company that a second pivotal efficacy study is not required for the Company’s LEVADEX(TM) new drug application (NDA) submission for the acute treatment of migraine…
Ask anyone who suffers from migraine headaches what they do when they’re having an attack, and you’re likely to hear “go into a dark room.” And although it’s long been known that light makes migraines worse, the reason why has been unclear…
New research shows that migraine and depression may share a strong genetic component. The research is published in the January 13, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology…
Zogenix, Inc. (”Zogenix”), a privately held pharmaceutical company, and Astellas Pharma U.S., Inc. (”Astellas”) announced the U.S. commercial launch of SUMAVEL™ DosePro™ (sumatriptan injection) needle-free delivery system. In July 2009, the U.S…
Use of most electronic media is not associated with headaches, at least not in adolescents. A study of 1025 13-17 year olds, published in the open access journal BMC Neurology, found no association between the use of computer games, mobile phones or television and the occurrence of headaches or migraines…
If you’re one of the millions of headache sufferers around the world, more effective relief might be on the way in years to come. That’s because the International Headache Society has just published new research guidelines intended to stimulate more research into headache treatment, and to provide researchers with guidelines to cut health risks associated with treatment…
The Plastic Surgery Center announced that a 57-year-old Plainfield man reports he is free of constant headache pain after undergoing a new cutting edge nerve procedure to permanently eliminate pain caused by migraines. The procedure was performed by plastic and reconstructive surgeon Dr. Matthew Kaufman, of the Plastic Surgery Center in New Jersey on August 4, 2009…
Zogenix, Inc. (”Zogenix”), a privately held pharmaceutical company, and Astellas Pharma US, Inc. (”Astellas”) announced that positive results from two clinical studies of new SUMAVEL DosePro (sumatriptan injection) needle-free delivery system will be published in the November 2009 issue of Headache…
On the publication of research in the British Medical Journal looking at the links between migraine and an increased risk of stroke, Ellen Mason, Cardiac Nurse at the British Heart Foundation said: ‘This review clarifies that it is only migraine with aura – a migraine with temporary visual and sensory disturbances that is linked to increased risk of having a stroke…
Migraine with aura (temporary visual or sensory disturbances before or during a migraine headache) is associated with a twofold increased risk of stroke, finds a study published on bmj.com today. Further risk factors for stroke among patients with migraine are being a woman, being young, being a smoker, and using oestrogen containing contraceptives…
A migraine with aura occurs when temporary visual or sensory disturbances are experienced before or during a migraine headache. A study just published on bmj.com reports that migraine with aura is associated with a twofold increased risk of stroke…
Inflammatory response of brain cells – as indicated by a molecular imaging technique – could tell researchers more about why certain neurologic disorders, such as migraine headaches and psychosis in schizophrenic patients, occur and provide insight into how to best treat them, according to two studies published in the November issue of The Journal of Nuclear Medicine…
Pooling results from 21 studies, involving 622,381 men and women, researchers at Johns Hopkins have affirmed that migraine headaches are associated with more than twofold higher chances of the most common kind of stroke: those occurring when blood supply to the brain is suddenly cut off by the buildup of plaque or a blood clot. The risk for those with migraines is 2…
Angst could be more than a rite of passage for insecure teenagers, according to a study published in The Journal of Pain. Researchers from the Université de Montréal, the Sainte-Justine University Hospital Center and McGill University have discovered that insecure adolescents experience more intense pain in the form of frequent headaches, abdominal pain and joint pain…
